Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

STERIS plc

STENYSEEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 12, 2026Accepted Aug 12, 2026, 4:32 PM EDTFiling CIK 1757898Accession 0001628280-26-056261
Share

Structured filing — 4

wk-form4_1786566720.xml

Open full document ↗

Filing details

Report period
2026-08-10
Issuer
STERIS plc
Issuer CIK
0001757898
Trading symbol
STE

Reporting owner 1

Name
FELDMANN CYNTHIA L
Reporting owner CIK
0001264554
Relationship
Director
Address
C/O 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND, L2, D02 R296

Derivative transactions

Derivative transactions · 2 reported rows
SecurityConversion / exercise price (USD)Transaction dateCodeAmountA / DPrice (USD)ExercisableExpiresUnderlying securityUnderlying sharesOwned afterOwnership
Director Stock Option (right to buy)238.912026-08-10A · Form 41,506A0[F1]2036-08-10Ordinary Shares1,5061,506D
Career Restricted Stock Units[F2]2026-08-10A · Form 4512A0[F3][F3]Ordinary Shares5128,640D
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct

Footnotes

F1
These nonqualified stock options are fully vested and are exercisable immediately.↩ 1
F2
Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.↩ 1
F3
These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.↩ 1↩ 2

Signature 1

Signed
/s/ John P. Ubbing, Authorized Representative under Power of Attorney
Date
2026-08-12

Company context

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit www.steris.com.

Current securities

Recent company filings

  1. Entry into a Material Definitive AgreementOct 13, 2026
  2. 4 filingOct 5, 2026
  3. 144 filingAug 18, 2026
  4. 4 filingAug 12, 2026
  5. 4 filingAug 12, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.